Drugs / Ivoximab
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07599371 | Oct 2024 → Oct 2027 expected | glioma | The First Affiliated Hospital of Zhengzhou University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ivoximab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07599371 ↗ |
| Route | Intravenous | “ivgtt” NCT07599371 ↗ |